Activity of BRAF Inhibitor Plixorafenib (FORE8394) in Advanced Ovarian Cancer Harboring BRAF V600E Mutation

October 21, 2024 9:35 AM EDT

Read More

Press Release Oct 08 2024 FORE Biotherapeutics Presents at RBC Capital Markets 2024 Virtual Biotechnology Private Company Conference Read more

Press Release Sep 26 2024 FORE Biotherapeutics Presents at UBS 2024 Biotechnology Private Company Virtual Symposium Read more

Press Release Sep 04 2024 FORE Biotherapeutics to Participate in Upcoming Investor Conferences Read more